Kyrgyzstan vs Republic of Moldova: Share of people with HIV who receive antiretroviral therapy
Kyrgyzstan
53.0%
in 2024
Republic of Moldova
53.0%
in 2024
Kyrgyzstan rank
115th
Republic of Moldova rank
115th
Share of people with HIV who receive antiretroviral therapy over time
- Kyrgyzstan
- Republic of Moldova
How they compare
Kyrgyzstan currently reports 53.0% against 53.0% in Republic of Moldova, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Republic of Moldova ahead.
Kyrgyzstan ranks 115th and Republic of Moldova ranks 115th of 143 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 1.6% | 0.5% | Kyrgyzstan |
| 2010s | 24.7% | 20.4% | 4.3% | Kyrgyzstan |
| 2020s | 47.6% | 46.0% | 1.6% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Kyrgyzstan or Republic of Moldova?
- Kyrgyzstan, at 53.0% against 53.0% in Republic of Moldova as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Kyrgyzstan and Republic of Moldova?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Kyrgyzstan and Republic of Moldova rank globally for share of people with hiv who receive antiretroviral therapy?
- Kyrgyzstan ranks 115th and Republic of Moldova ranks 115th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.